← Eichor
Study identifier: NCT03513731 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safety of Adipose-derived Regenerative Cells Injection for Treatment of Osteoarthritis of the Facet Joint

Condition: Osteoarthritis of Facet Joint of Lumbar Spine  ·  Sponsor: InGeneron, Inc.

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This is a prospective, randomized, active controlled, single site safety and efficacy study in subjects suffering from chronic lumber back pain due to facet joint osteoarthritis comparing a single ADRC injection generated with the Transpose® RT system into the facet joint.

This description comes directly from the study's public registry record.

Talk to the study team

Brian Caballero  ·  (713) 440-9900  ·  bcaballero@ingeneron.com

Always discuss trial participation with your own doctor first.

Locations (2)

Sports and Orthopedic CenterDeerfield Beach, Florida, United StatesRecruiting
Sanford Physical Medicine & Rehabilitation Clinic and Sanford Spine CenterSioux Falls, South Dakota, United StatesCompleted

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03513731